multiple myeloma

News

Janssen's Darzalex approved for myeloma in Europe

Darzalex, a first-in-class treatment for multiple myeloma has been approved in Europe, adding to an increasingly competitive disease area.

News

BMS and AbbVie’s myeloma drug Empliciti gains approval

Multiple myeloma, one of the fastest-moving therapy areas, has just added another new treatment following FDA approval of Bristol-Myers Squibb's (BMS) and AbbVie's Empliciti (elotuzumab).

Articles

Celgene gets set for stellar growth in Europe

Janssen's Darzalex approved for myeloma in Europe

BMS and AbbVie’s myeloma drug Empliciti gains approval

Celgene gets set for stellar growth in Europe

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks